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Abstract
Background: Percutaneous coronary intervention (PCI) has increased as the initial revascularization strategy in chronic 
coronary artery disease. Consequently, more patients undergoing coronary artery bypass grafting (CABG) have history 
of coronary stent.
Objective: Evaluate the impact of previous PCI on in-hospital mortality after CABG in patients with multivessel coronary 
artery disease. 
Methods: Between May/2007 and June/2009, 1099 consecutive patients underwent CABG on cardiopulmonary bypass. 
Patients with no PCI (n=938, 85.3%) were compared with patients with previous PCI (n=161, 14.6%). Logistic regression 
models and propensity score matching analysis were used to assess the risk-adjusted impact of previous PCI on in-
hospital mortality. 
Results: Both groups were similar, except for the fact that patients with previous PCI were more likely to have unstable 
angina (16.1% x 9.9%, P=0.019). In-hospital mortality after CABG was higher in patients with previous PCI (9.3% x 
5.1%, P=0.034) and it was comparable with EuroSCORE and 2000 Bernstein-Parsonnet risk score. Using multivariate 
logistic regression analysis, previous PCI emerged as an independent predictor of postoperative in-hospital mortality 
(odds ratio 1.94, 95% CI 1.02-3.68, P=0.044) as strong as diabetes (odds ratio 1.86, 95% CI 1.07-3.24, P=0.028). After 
computed propensity score matching based on preoperative risk factors, in-hospital mortality remained higher among 
patients with previous PCI (odds ratio 3.46, 95% CI 1.10-10.93, P=0.034). 
Conclusions: Previous PCI in patients with multivessel coronary artery disease is an independent risk factor for in-
hospital mortality after CABG. This fact must be considered when PCI is indicated as initial alternative in patients with 
more severe coronary artery disease. (Arq Bras Cardiol. 2012; [online].ahead print, PP.0-0)
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Introduction
Despite all scientific evidences and the guidelines for the 
treatment of chronic coronary artery disease demonstrating 
the benefits of coronary artery bypass grafting (CABG), 
especially in patients with multivessel disease, there has 
been an exponential growth in percutaneous coronary 
intervention (PCI) with stents1,2. With technological 
advances and the experience accumulated over the years, 
the indication for PCI has expanded and procedures in 
multivessel coronary disease have become more common3,4.
In this so-called “stent era”, patients with coronary 
artery disease and class I indication for CABG are 
frequently submitted to PCI as initial alternative, before 
being convinced to surgical treatment5. Some studies have 
shown restenosis rates after PCI with stent, with need 
of reintervention due to symptom recurrence, ranging 
from 20% to 40%6,7. More recently, it has been discussed 
whether previous PCI is a risk factor with negative impact 
on the outcomes of CABG8-10. A significant inflammatory 
process and endothelial function abnormalities in the 
coronary arteries have been related to the treatment with 
stent, especially when drug-eluting stents were used11-13. 
However, the actual clinical impact of the presence of 
stents in the coronary artery in the prognosis of CABG has 
not been clearly established and it is controversy14,15. The 
increase in mortality is the main event that can influence 
changes in the guidelines. 
The objective of this study is to assess the impact 
of previous PCI with stent as risk factor for in-hospital 
mortality in patients with multivessel chronic coronary 
artery disease who requiring later surgical treatment for 
myocardial revascularization.
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The Hosmer–Lemeshow goodness-of-fit statistic test was 
used to compare the observed and predicted mortality with 
95% confidence intervals. A well-calibrated model gives 
corresponding p > 0.05.
Univariate and multivariate logistic regression models 
were used to identify associated factors and independent 
preoperative predictors for in-hospital mortality. The variables 
identified by the univariate analysis with a p value ≤ 0.10 were 
used to the adjustment of the multivariate logistic regression 
model (forward procedure).
In an additional effort to minimize the influence from a 
non-randomized study, a second analysis was performed using 
the propensity score matching. Patients with prior PCI (study 
group) were matched with patients without prior PCI (control 
group), at a 1:1 ratio. After matching, in-hospital mortality 
was compared between the two groups. Paired samples 
were also reevaluated using the univariate and multivariate 
logistic regression tests, in order to control eventual risk factor 
selection bias.
The analysis was done using two-tailed tests and p <0.05 
was considered statistically significant. The SPSS software version 
18.0 was used for statistical analysis (SPSS Inc, Chicago, Illinois).
Results
Patients characteristics
From May 2007 to July 2009, 1551 patients were submitted 
to first time isolated CABG at the Heart Institute University of 
Sao Paulo Medical School. Four hundred and twenty-nine 
patients were excluded because they were operated without 
cardiopulmonary bypass or because they were submitted to PCI 
during the same hospitalization as the surgical treatment, 15 
patients were excluded because they were submitted to vascular 
procedures associated to CABG and 8 patients were excluded 
due to incomplete information regarding prior angioplasty. The 
other 1099 patients were the final study population. 
Of the 1099 patients included in the study, 938 (85.3%) 
patients underwent CABG without previous PCI and 161 
(14.6%) patients had previous PCI. Of these, 147 (91.3%) 
had been submitted to PCI using bare metal stents and 14 
(8.7%) using drug-eluting stents. The comparison of patients 
with and without prior PCI taking into consideration clinical 
manifestation and preoperative risk factors showed that 
patients with prior PCI had a more frequent unstable angina 
(16.1% vs. 9.9%, p=0.019) at the time of hospitalization. 
There were no others statistical differences between the 
two groups as to the remaining clinical manifestations and 
preoperative cardiovascular risk factors (Table 1).
Surgical treatment
In the intraoperative, patients with prior PCI had lower 
mean number of revascularized coronary arteries (3.0 vs 3.2 – 
p=0.446), longer aortic clamping time (76.1 vs. 74.8 minutes, 
p=0.673) and longer cardiopulmonary bypass time (90.7 vs 85.3 
minutes, p=0.584), however, there was no statistical significance. 
There were also no differences between the two groups regarding 
the use of left internal thoracic artery (95.2% vs 97.3%, p=0.386).
Patients and methods
A prospective observational design was used. All patients 
who underwent first-time isolated CABG surgery on 
cardiopulmonary bypass between May 2007 and July 2009 
were included in this study. The study group consisted of 
1,099 consecutive patients of mean age 63.6 ± 12.6 years 
who underwent elective, urgent or emergency CABG surgery. 
All patients had multivessel atherosclerotic coronary disease. 
Patients with combined cardiac surgery were excluded. 
CABG without cardiopulmonary bypass and reoperations 
were excluded to minimize surgical technique interferences. 
Patients underwent previous PCI in the same hospitalization 
as the surgery, were also excluded. All patients were operated 
at Heart Institute University of Sao Paulo Medical School, a 
tertiary referral national center and data were prospectively 
collected, creating a database.
Patient characteristics and preoperative risk factors were 
analyzed, following the additive European System for Cardiac 
Operative Risk Evaluation (EuroSCORE) and 2000 Bernstein-
Parsonnet logistic risk model16,17. The correlation of predicted 
and observed mortality was compared with these two models, 
for better evaluation. The outcome was in-hospital surgical 
mortality, defined as death occurring in the time interval 
between surgery and hospital discharge.
This study was approved by the Scientific and Ethics 
Committee of Heart Institute, University of São Paulo 
Medical School.
Surgical procedure
CABG was performed with cardiopulmonary bypass, 
using the classic technique by median sternotomy in all 
patients. Five hundred UI/Kg of heparin was used to obtain 
an activated coagulation time greater than 400 seconds. 
Myocardial protection was achieved with intermittent 
hyperkalemic antegrade warm blood cardioplegia or with 
intermittent aortic clamping. Protamine was used for heparin 
reversal at a ratio of 1:1. At the end of surgery, patients were 
transferred to the intensive care unit and managed according 
to the unit protocol.
Patients receiving dual anti-platelet therapy with 
acetylsalicylic acid and clopidogrel prior surgery were 
treated as follows: acetylsalicylic acid was discontinued on 
surgery day and was reintroduced the day following surgery, 
clopidogrel was discontinued at least 2 to 5 days prior surgery 
and, if required, it was reintroduced within at least 2 days 
after surgery.
Statistical analysis
Variables are shown in contingency tables with absolute (n) 
and relative (%) frequencies. Association among them, taking 
into consideration the groups with and without prior PCI, was 
evaluated by the chi-squared test, the likelihood ratio test or 
Fisher’s exact test. 
Quantitative variables were shown in tables including the 
median, and 1st and 3rd quartile values. The distribution of 
variables was evaluated by Mann-Whitney’s test.
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In-Hospital mortality
The overall mortality according to the additive EuroSCORE 
and 2000 Bernstein-Parsonnet risk model are showing, 
respectively, in Table 2 and Table 3. Patients with prior PCI had 
a significantly higher in-hospital mortality than those who did 
not have a prior intervention (9.3% vs. 5.1%, p=0.034). After 
adjustment with univariate analysis and later on with multivariate 
logistic regression for differences in clinical manifestations and 
preoperative risk factors, prior PCI emerged as an independent 
risk factor for in-hospital mortality after CABG with odds ratio 
of 1.94 (95% confidence interval 1.02 - 3.68; p=0.044). 
Other factors such as age, pulmonary hypertension, diabetes, 
congestive heart failure and preoperative intra-aortic balloon 
pump were also classified (Table 4).
Patient matching
Propensity score matching was performed taking into 
consideration preoperative factors with a greater impact on 
surgery to match study group (patients with previous PCI) and 
control group (patients without previous PCI). The following 
parameters were selected: gender, age, diabetes, systemic 
hypertension, congestive heart failure, unstable angina, recent 
myocardial infarction. For this analysis, 161 study group 
patients were successfully paired with 161 corresponding 
controls at a ratio of 1;1 (Table 5). When in-hospital mortality 
was compared between the two groups, patients with prior 
PCI had significantly higher in-hospital mortality after CABG 
(9.3% vs. 3.1%, p=0.021). After univariate and multivariate 
analysis with the paired groups, to control eventual variables 
not selected for the matching, PCI emerged once again as an 
independent predictor for in-hospital mortality after CABG 
with odds ratio of 3.46 (95% confidence interval 1.10- 10.93; 
p=0.034) (Table 6).
Discussion 
Impact of prior PCI on in-hospital mortality after CABG
Cardiovascular surgeons have more and more often been 
faced with patients referred for CABG after a successful 
previous PCI. This study clearly showed, based on a database 
created for a prospective analysis with adjustment of risk 
factors, that previous PCI is an independent risk factor for 
in-hospital mortality after CABG.
Mortality risk factors after cardiac surgery have been studied 
since the late 80s. Initially only using associations and later with 
risk stratification models18,19. Many variables, including PCI at 
the same hospitalization, have been studied and known for a 
long time as in-hospital mortality predictors after CABG16,17,20. 
The influence of previous PCI on CABG has been observed for 
cardiac surgeons in daily practice. However, it has not been 
extensively studied and only recently, it has been taken into 
account more seriously.
In 1995, Johnson et al21 observed negative impact of a 
previous PCI on CABG. Comparing 234 patients successfully 
submitted to angioplasty who later required CABG, they 
observed that surgical risk at the time of surgery was 4.0%, 
significantly higher than the 2.8% prior angioplasty (p=0.04). 
In 1996, Jones et al22 in extensive review of seven large 
databases with 172,184 patients underwent CABG were the 
first to identify previous PCI as a risk factor. At the time, it 
was classified as level 2, i.e., not clearly related to mortality 
after surgery. In 1998, Kalaycioglu et al23 in a propensity score 
matching with 80 patients underwent CABG observed worse 
outcomes in the group of patients with previous coronary 
angioplasty. More recently, Hassan et al8 in a large study with 
6504 patients underwent CABG (919 patients with a previous 
PCI), clearly demonstrated that previous PCI is an independent 
predictor for in-hospital mortality after CABG, odds ratio 
of 1.93 (p=0.003). However, nowadays still have doubt if 
previous PCI is a risk factor for patients who undergoing CABG. 
In the last years, there is an increasing number of 
interventional procedures using stents in intermediate risk 
patients as well as in patients with more severe multivessel 
coronary disease, which used to be considered inadequate 
for PCI3,4,24. As consequence, there are an increasing number 
of patients who have been submitted to PCI with stents 
before being finally referred for CABG. In the literature, 
this incidence ranges from 10% to 20%8-10. From our study 
group, 161 patients (14.6%) had previous PCI. In this context, 
it is important to reassess the clinical relevance of previous 
PCI and the prognostic value of risks in patients who may 
require later CABG. 
Recent report, with post hoc analysis, patients with history 
of PCI had worse prognosis after CABG and an increase in 
cardiovascular events during clinical follow-up25. Bonaros 
et al26 confirmed these data in study with 306 patients with 
previous PCI who were matched with similar group without 
PCI prior to CABG. Patients with previous PCI had higher in-
hospital mortality (4.4% vs. 2.4%, p<0.001).
In the present study, the analysis of 1099 consecutive 
patients underwent CABG on cardiopulmonary bypass the 
overall hospital mortality was 5.7%. This observed mortality 
reflect the high complexity presented in tertiary service of 
national reference and it was comparable with predicted 
mortality based on the additive EuroSCORE and 2000 
Bernstein-Parsonnet logistic risk model27,28. The mortality 
was greater in patients with a history of previous PCI (9.3% 
vs 5.1%, p<0.034). Logistic regression models indicated that 
previous PCI with stent was an independent predictor for 
in-hospital mortality after CABG with an odds ratio of 1.94 
(p=0.044). Propensity score matching confirmed previous 
PCI as a risk factor for in-hospital mortality after CABG (odds 
ratio of 3.46, p=0.034). 
Even though several studies have shown that the previous 
PCI using stents is risk factor for in-hospital mortality after 
CABG, this correlation is still controversial. Some groups 
believe there is no correlation between previous PCI and 
subsequent CABG14. Others have found this correlation only 
in patients receiving multiple coronary interventions or in 
diabetic patients9,29-31. Yap et al14 analyzed 13,184 patients 
(1,457 with history of PCI) underwent CABG and did not 
find an association between previous PCI and early or mid 
term mortality (odds ratio of 1.11, p=0.41). Thielmann et 
al29 analyzed 2626 patients undergoing CABG and found 
an association between previous PCI and hospital mortality, 
however, it was only significant in the presence of multiple 
previous PCIs (odds ratio of 2.24; p<0.001). Massoud et al9 
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Table 1 - Comparison of clinical manifestations and preoperative cardiovascular risk factors between patients submitted to isolated CABG 
with previous PCI and those without PCI
Variables Without previous PCI (n=938)
With previous 
PCI (n=161) p
Age (years) 62 (56 - 70) 63 (56 - 69) 0.863 c
Female sex 254 27.1% 36 22.4% 0.209 a
Ejection fraction (%) 60 (45 - 65) 56 (45 - 62) 0.135 c
Left main disease > 50% 188 20.0% 24 14.9% 0.127 a
Clinical manifestation
Congestive heart failure 419 44.7% 79 49.1% 0.300 a
Unstable angina 93 9.9% 26 16.1% 0.019 a
Recent AMI 247 26.3% 53 32.9% 0.083 a
AMI with < 48hs 35 3.7% 10 6.2% 0.142 a
Cardiogenic shock 5 0.5% 1 0.6% 1.000 b
Preoperative IABP 32 3.4% 9 5.6% 0.178 a
CV risk factors
Diabetes 449 47.9% 71 44.1% 0.376 a
Systemic hypertension 819 87.3% 147 91.3% 0.151 a
Morbid obesity 109 11.6% 19 11.8% 0.947 a
Renal insufficiency 48 5.1% 8 5.0% 0.937 a
Dialysis 12 1.3% 1 0.6% 0.705 b
COPD 20 2.1% 3 1.9% 1.000 a
Pulmonary hypertension 65 6.9% 10 6.2% 0.738 a
Emergency surgery 26 2.8% 6 3.7% 0.506 a
a-chi-squared test; b-Fisher’s exact test; c-Mann-Whitney’s test. Variables are shown in contingency table with absolute (n) and relative (%) frequencies. Quantitative 
variables were shown in table including the median, and 1st and 3rd quartile values. CABG - Coronary artery bypass grafting; PCI - Percutaneous coronary intervention; 
AMI - Acute myocardial infarction; IABP - Intra-aortic balloon pump; CV - Cardiovascular; COPD - Chronic obstructive pulmonary disease.
Table 2 – Predicted and observed mortality by additive EuroSCORE risk model for whole study group
Mortality *
EuroSCORE group Patients % observed(95% CI)
% predicted
(95% CI)
≤ 2 459 1,53 1,74
(0,40; 2,65) (0,55; 2,94)
3 – 5 397 4,28 4,03
(2,29; 6,27) (2,10; 5,96)
≥ 6 243 16,05 16,05
(11,43; 20,66) (11,43; 20,66)
* Hosmer–Lemeshow goodness-of-fit test (p=0,412)
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Table 3 – Predicted and observed mortality by 2000 Bernstein-Parsonnet risk model for whole study group
Mortality *
2000 Bernstein Parsonnet Risk group Patients % observed(IC a 95%)
% predicted
(IC a 95%)
≤ 6 218 1,38 1,38
(0,17; 2,92) (0,17; 2,92)
6,1 – 11,0 237 0,84 1,69
(0,32; 2,01) (0,05; 3,33)
11,1 – 15,0 216 3,70 3,24
(1,19; 6,22) (0,88; 5,60)
15,1 – 20,9 226 4,42 5,75
(1,74; 7,11) (2,72; 8,79)
≥ 21 202 19,80 17,82
(14,31; 25,30) (12,54; 23,10)
* Hosmer–Lemeshow goodness-of-fit test (p=0,890)
Table 4 - Univariate and multivariate logistic regression analysis of variables associated with in-hospital mortality after CABG
Variables
Univariate analysis Multivariate analysis
odds ratio 
(95% CI) p
odds ratio 
(95% CI) p
Age (years) 1.07 (1.04 – 1.10) <0.001 1.06 (1.03 – 1.09) <0.001
Female sex 1.66 (0.97 – 2.82) 0.063
Ejection fraction (%) 0.97 (0.96 – 0.99) 0.003
Left main disease > 50% 1.74 (0.98-3.07) 0.037
Clinical manifestation
Congestive heart failure 2.97 (1.71 – 5.16) <0.001 2.15 (1.2 – 3.85) 0.010
Unstable angina 4.06 (1.94 – 8.49) <0.001
Recent AMI 2.10 (1.25 – 3.52) 0.005
AMI with < 48hs 3.93 (1.75 – 8.84) 0.001
Cardiogenic shock 8.46 (1.52 – 47.09) 0.015
Preoperative IABP 9.36 (4.57 – 19.16) <0.001 6.6 (3.09 – 14.08) <0.001
CV risk factors
Diabetes 1.63 (0.97 – 2.73) 0.064 1.86 (1.07 – 3.25) 0.028
Systemic hypertension 1.33 (0.56 – 3.14) 0.519
Morbid obesity 1.47 (0.73 – 2.96) 0.284
Renal insufficiency 4.06 (1.94 – 8.49) <0.001
Dialysis 1.38 (0.18 – 10.76) 0.761
COPD 2.54 (0.73 - 8,79) 0.141
Pulmonary hypertension 3.63 (1.84 – 7.16) <0.001 1.02 (1.01 – 1.04) 0.006
Emergency surgery 6.13 (2.64 – 14.28) <0.001
Previous PCI 1.90 (1.04 – 3.491) 0.037 1.94 (1.02 – 3.68) 0.044
CABG - Coronary artery bypass grafting; CI - Confidence interval; AMI - Acute myocardial infarction; IABP - Intra-aortic balloon pump; CV - Cardiovascular; COPD, 
-Chronic obstructive pulmonary disease; PCI - Percutaneous coronary intervention.
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Table 5 - Preoperative characteristics in patients matched on propensity score with previous PCI (study group) and those without previous 
PCI (control group)
Variable Without previous PCI (n=161)
With previous 
PCI (n=161) p
Age (years) 63 (56 - 69) 70 (61 - 76) 0.800 c
Female sex 38 23.6% 23 36.5% 0.791 a
Ejection fraction (%) 57 (42 - 62) 56 (45 - 62) 0.809 c
Left main disease > 50% 33 20.5% 24 14.9% 0.189 a
Clinical manifestation
Congestive heart failure 83 51.5% 79 49.1% 0.656 a
Unstable angina 20 12.4% 26 16.1% 0.339 a
Recent AMI 53 32.9% 53 32.9% 1.000 a
AMI with < 48hs 5 3.1% 10 6.2% 0.186 b
Cardiogenic shock 1 0.6% 1 0.6% 1.000 b
Preoperative IABP 7 4.3% 9 5.6% 0.608 b
CV risk factors
Diabetes 71 44.1% 71 44.1% 1.000 a
Systemic hypertension 140 87.0% 147 91.3% 0.210 a
Morbid obesity 15 9.3% 19 11.8% 0.468 a
Renal insufficiency 11 6.8% 8 5.0% 0.478 a
Dialysis 1 0.6% 1 0.6% 1.000 b
COPD 2 1.2% 3 1.9% 0.686 b
Pulmonary hypertension 12 7.4% 10 6.2% 0.659 a
Emergency surgery 6 3.7% 6 3.7% 1.000 b
a-chi-squared test; b-Fisher’s exact test; c-Mann-Whitney’s test. Variables are shown in contingency table with absolute (n) and relative (%) frequencies. Quantitative 
variables were shown in table including the median, and 1st and 3rd quartile values. PCI - Percutaneous coronary intervention; AMI - Acute myocardial infarction; IABP 
- Intra-aortic balloon pump; CV - Cardiovascular; COPD - Chronic obstructive pulmonary disease.
in multicenter study with almost 30,000 patients confirmed 
the history of multiple previous PCIs as risk factor for hospital 
mortality after CABG (odds ratio of 2.02; p=0.0005). In a 
sub-analysis with 749 diabetic patients, Thielmann et al31, 
observed the association of hospital mortality after CABG 
with odds ratio of 2.87 (p=0.03) for diabetic patients with a 
history of previous PCI. In our study group (with previous PCI), 
90 patients (56.0%) did not have diabetes and 136 patients 
(84.5%) had only one previous PCI, even so previous PCI 
was an independent risk factor. This risk had similar impact 
as diabetes (odds ratio of 1.86, p=0.028) and chronic renal 
failure (odds ratio of 4.80, p=0.029), risk factors which have 
long been known and accepted by the medical community. 
Negative influence mechanism
There are several possible causes that may explain the 
negative impact of previous PCI using stents on CABG:
1- One of them might be stent thrombosis, which takes place 
more frequently in the first six months after the procedure, and 
mainly when antiplatelet drugs are discontinued early on to 
carry out surgery. This thrombotic risk is greater when more than 
one stent is used, with long stents, stents placed in bifurcations, 
drug-eluting stents, diabetic patients and in renal failure32. In our 
casuistic, this could explain the cause of approximately 1/3 of 
the patients operated on within less than 12 months of the PCI. 
2 – Another cause might be the number of coronary 
anastomoses or incomplete revascularization in this group 
of patients. The most common reasons are occluded 
coronary arteries or those with multiple stents. Incomplete 
revascularization may lead to postoperative events such as 
myocardial infarct and death33. In our casuistic, patients with 
previous PCI had a lower number of coronary anastomosis 
per patient (3.0 vs. 3.2 in the group without a previous 
intervention), however there was no statistical difference.
3 – The need to perform coronary anastomosis more distally 
than usual (as a result of the presence of stents in the mid third 
of the arteries) may also affect surgery. In this region, arteries 
have a smaller diameter, greater flow resistance and it is more 
difficulty to perform coronary anastomosis. This is a mechanic 
cause, related to the surgical technique, which is difficult to 
quantify and assess, but definitely plays a major role in the 
early outcomes of the surgical treatment. 
4 - A fourth cause may be the presence of multiple coronary 
interventions, impairing native blood flow by collaterals 
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Table 6 - Univariate and multivariate logistic regression analysis of variables associated with in-hospital mortality after CABG in patients 
matched on propensity score
Variable
Univariate analysis Multivariate analysis
odds ratio 
(95% CI) p
odds ratio 
(95% CI) p
Age (years) 2.41 (0.31 – 18.58) 0.398 1.11 (1.04 – 1.18) 0.001
Female sex 1.13 (0.4 – 3.21) 0.825
Ejection fraction (%) 0.99 (0.96 – 1.02) 0.501
Left main disease > 50% 1.60 (0.56 – 4.6) 0.381
Clinical manifestation
Congestive heart failure 2.43 (0.91 – 6.49) 0.077
Unstable angina 4.63 (1.78 – 12.06) 0.002
Recent AMI 4.17 (1.61 – 10.8) 0.003
AMI with < 48hs 13.95 (4.36 – 44.68) <0.001 16.43 (4.17 – 64.65) <0.001
Cardiogenic shock - -
Preoperative IABP 17.53 (5.64 – 54.44) <0.001
CV risk factors
Diabetes 1.29 (0.52 – 3.19) 0.584
Systemic hypertension 2.41 (0.31 – 18.58) 0.398
Morbid obesity 3.14 (1.06 – 9.26) 0.038 4.15 (1.21 – 14.19) 0.023
Renal insufficiency 4.78 (1.42 – 16.08) 0.011 4.80 (1.17 – 19.74) 0.029
Dialysis - -
COPD - -
Pulmonary hypertension 2.63 (0.71 – 9.76) 0.149
Emergency surgery 3.24 (0.66 – 15.93) 0.147
Previous PCI 3.21 (1.14 – 9.04) 0.028 3.46 (1.1 – 10.93) 0.034
CABG - Coronary artery bypass grafting; CI - Confidence interval; AMI - Acute myocardial infarction; IABP - Intra-aortic balloon pump; CV - Cardiovascular; COPD - 
Chronic obstructive pulmonary disease; PCI - Percutaneous coronary intervention.
causing micro myocardial infarctions. As a consequence, there 
is more flow resistance of the grafts and lower myocardial 
irrigation9,34. In our experience, most of the patients (84.5%) 
had only one previous PCI and this fact could be the cause 
of only 15% of the patients.
5 – The severity of the progression of coronary atherosclerotic 
disease may justify the greater mortality. Currently, patients 
undergoing PCI with a stent have more severe atherosclerotic 
disease, but not as severe as those undergoing surgical treatment. 
When treatment fails, these patients are referred for surgical 
revascularization, however the atherosclerotic disease is then 
more severe and diffuse35. In our casuistic, preoperative clinical 
factors and the presence of left main lesion were similar between 
the two groups, which leads to the conclusion that the presence 
of the stent may have worsened the progression of atherosclerotic 
disease and delayed the optimal time for surgical treatment.
6 – More recently, endothelial abnormalities caused by 
the presence of stents have been studied. There is evidence 
indicating the coronary stents cause lesions in the arterial wall, 
leading to endothelial dysfunction with a chronic inflammatory 
response and platelet and neutrophil activation. The 
inflammatory and proliferative abnormalities are not limited 
to the treated coronary. It affects other coronary arteries, 
surrounding tissues, including the myocardium, causing 
adverse cardiovascular effects. Endothelial abnormalities may 
also render coronary anastomosis more difficult, affecting the 
perviousness of the grafts11-13. This is common in bare metal 
stents and is even more intense in drug-eluting stents13. In our 
casuistic, only 8% of the patients had a previous intervention 
with drug-eluting stents. If on one hand, there are evidences 
that drug-eluting stents cause greater inflammatory and chronic 
response and therefore may further increase surgical risk, on 
the other hand they may reduce the need of reinterventions 
and decrease the number of patients requiring CABG after 
PCI. This association should be further studied.
The mechanism associated with worse prognostic after CABG 
in patients with previous PCI is multifactorial and probably 
is caused by a chronic inflammatory reaction, endothelial 
dysfunction, myocardial ischemic events and changes or difficulty 
of the surgical technique15,36. Critical analysis and larger and more 
comprehensive studies should be carried out to establish this 
association and its respective mechanisms.
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Study limitations
This type of study cannot be randomized and the 
comparison between groups with and without previous PCI 
has clear limitations, especially regarding the different sample 
sizes. Even if the propensity score matching is used, the 
analysis is not ideal, since it depends on selected variables 
for matching. The type of previous PCI was also not detailed. 
It was not known whether there was any other procedure 
in addition to stent implantation or whether there was any 
other complication. Different causes for surgical treatment 
indication were also not separated among patients with a 
previous PCI, such as restenosis, occlusion, thrombosis or 
disease progression.
Conclusion
Previous PCI is an independent risk factor for in-hospital 
mortality in patients with multivessel coronary artery disease 
who requiring later CABG for coronary artery disease. The 
cardiac surgeons have to be mindful of this, just as they are 
already had with other factors, such as renal failure and diabetes.
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